Oxymatrine alleviates high-fat diet/streptozotocin-induced non-alcoholic fatty liver disease in C57BL/6  J mice by modulating oxidative stress, inflammation and fibrosis

In conclusion, OMT improved liver impairment effectively in diabetic mice by suppressing oxidative stress, inflammation and fibrosis. These results suggest that OMT may represent a novel therapy for NAFLD with diabetes.PMID:38537582 | DOI:10.1016/j.biopha.2024.116491

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - March 27, 2024 Category: Drugs & Pharmacology Authors: Di Lou Qing Fang Yinghao He Ruyu Ma Xinyan Wang Hanbing Li Minyou Qi Source Type: research